Facebook Linkedin RSS Twitter Youtube
Home 2024

Policy

Modeling Clonal Evolution in Hematopoietic Malignancies
Cancer

Modeling Clonal Evolution in Hematopoietic Malignancies

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational
Bioprocessing

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational

Techno-Economic Analyses Link Process Parameters to Financial Metrics
Bioprocessing

Techno-Economic Analyses Link Process Parameters to Financial Metrics

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s
Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases
Bioprocessing

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress

New Research Power Ups Psilocybin’s Potential as an Antidepressant
News

New Research Power Ups Psilocybin’s Potential as an Antidepressant

Bad Facts Make for Horrible Health Policy
BioPerspectives

Bad Facts Make for Horrible Health Policy

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Drug Discovery

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B

123...31Page 1 of 31
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.